Join the DDA or

Mefenamic acid single batch recall

Film problems with Quadrant product

May 18th 2022

Tagged: MHRA alert


Quadrant Pharmaceuticals Ltd is recalling a specific batch of mefenamic acid 500mg film-coated tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets. This has resulted in the tablet core being partially exposed.

 The affected batch is as follows:

Batch numberCompany’s ReferenceExpiry datePack sizeFirst distributed

Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

For more information, medical or supply enquiries, please contact [email protected] or [email protected]